Introduction 27
The leucine-rich repeat kinase 2 (LRRK2) LRRK2 were also found in sporadic cases, and are the most common genetic cause of PD (Healy et 31 al., 2008) . Not every mutation carrier develops overt disease because penetrance is incomplete and 32 age-dependent, estimated to 25% -74% at the age of 80 for the most prevalent mutation G2019S 33 by Nichols, 2017) . LRRK2 is involved in many cellular processes (reviewed by Wallings et al., 2015) , 41 some of them becoming more and more dysregulated in the aging brain like protein degradation 42 
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Expression analysis and dose finding of HC-AdVs 246
We generated 3 HC-AdVs encoding either the disease-linked kinase-overactive LRRK2 mutant 247 G2019S, the kinase-inactive LRRK2 mutant D1994A or eGFP under the control of the ubiquitously 248 active CAG promoter. Transgene expression was confirmed by transduction and subsequent 249 immunocytochemistry of primary murine embryonic cortical neurons and astrocytes (Fig S1) . 250
Immunoblotting of lysates from primary cortical cells showed that despite high levels of total LRRK2 251 for either mutant (Fig. 1A) , only LRRK2_G2019S was capable of auto-phosphorylation at serine 252 residue 1292, confirming kinase inactivity of LRRK2_D1994A (Fig. 1B) . 253
The brain areas of main interest in PD are the Substantia Nigra pars compacta (SNpc), where 254 dopaminergic neurons originate from, and the striatum, their principal projection area. Based upon 255 prior publications recommending adenoviral vector injection into the striatum in order to avoid 256 unspecific injury and inflammation in and widespread virus distribution around the SNpc, we chose to 257 focus on striatal transduction as well (Dusonchet et al., 2011; Lewis et al., 2010) . We tested 4 doses of 258 LRRK2_D1994A HC-AdV or a UV-psoralen inactivated HC-AdV (1.25E+06 IU -5E+07 IU) 259 distributed across both striatal hemispheres and observed a very severe inflammatory reaction in the 260 LRRK2_D1994A mice at 3 weeks post-injection (wpi), especially for the two highest doses, while a 261 transient microglial response 7 days after injection of the inactivated vector had resolved at that time 262 (Fig. S2A, B, C) . In a second approach with only one injection per striatal hemisphere we found the 263 intermediate dose of 1.5E+06 IU to be best yielding widespread LRRK2 or eGFP signals while 264 microglial reaction remained in a tolerable range and mice did not lose weight (Fig. S2D, E) . With the 265 aim of wider distribution across the striatum, we finally decided for two adjacent injections with each 266 1E+06 IU for our longitudinal study. 267
Longitudinal in vivo study -comparison between young and old mice 268
In our longitudinal study, young (9-10 weeks) and old (19 months) male C57BL/6J mice were 269 monitored over 4 weeks (cohort 1), 3 months (cohort 2) or 6 months (cohort 3, only young mice). 270
Each cohort comprised 3 groups (eGFP, LRRK2_D1994A and LRRK2_G2019S) with n=9/group (n = 271 7/group for old cohort 1 due to limited availability of old mice). Weight, nest building capacity and 272 open field test performance were monitored over the lifetime of the mice, and histopathology wasM A N U S C R I P T
A C C E P T E D ACCEPTED MANUSCRIPT
extensively analyzed at the respective endpoints (Fig. 2) . Mice that did not reach their respective 274 endpoints were excluded from all analyses as were mice that did not show any transgene expression. 275
The eGFP group of old cohort 1 had to be excluded from the analysis due to absence of transgene 276 expression (4 week endpoint), likely due to a technical problem during injection. 277
No consistent LRRK2-dependent differences in weight, nest-building and motor 278
behavior of young and old mice 279
Weight was monitored closely in the first week after surgery and then twice a week. After a short 280 period of regeneration, young mice continuously gained weight with no group-specific differences for 281 cohorts 1 and 2 and a reduced weight gain for LRRK2_D1994A mice in cohort 3. Old mice needed 282 more time to recover from surgery and to gain back their original weight, but showed no significant 283 group-specific differences (Fig. S3) . Nest building as highly motivated and dopamine-dependent 284 natural behavior of mice (Sager et al., 2010) was quantified weekly by determining the percentage of 285 remaining pressed nesting material after one night without any further enrichment in the cage. Linear 286 regression analysis did not show any significant differences in the slope of regression lines between 287 the groups for all young and old cohorts as would have been expected in case of progressive 288 dopamine depletion (Fig. S4) . In the open field test the motor parameters distance traveled and 289 rearings as well as the anxiety-related parameter "time spent in center" were measured, weekly for 290 cohorts 1 and every 4 weeks for cohorts 2 and 3. We found no consistent differences in any of those 291 parameters between the groups for young or old mice. Observed trends pointed to a slightly increased 292 endurance in traveling for LRRK2_D1994A mice (Fig. S5) , a minor decrease in the number of 293 rearings at some points in time for LRRK2_G2019S mice (Fig. S6 ) and less time spent in the center 294 by old LRRK2_G2019S mice compared to the other age-matched treatment groups (Fig. S7) . In an 295 attempt to catch minor motor impairments that could have been overlooked in the open field test, 296 young mice from cohort 3 and old mice from cohort 2 were tested in the accelerating RotaRod and by 297 pole test 5 or 3 months post-injection (mpi), but again no significant differences between treatment 298 groups were found (Fig. S8) . In summary, no consistent behavioral differences between treatment 299 groups could be detected with the methods applied.
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Maintained striatal transgene expression over up to 6 months, but inefficient 301 retrograde transport to the SNpc 302
After having reached their respective endpoints, mice were perfused and serial sections of formalin-303 fixed paraffin-embedded striatum and nigra were prepared. Fourteen striatal 3 µm sections with 304 defined distance were stained for eGFP or LRRK2 to determine the center and the extent of 305 transduction. Optical density (OD) of the transgenic proteins was quantified in central sections and 306 found to be largely maintained over the analysis period of up to 6 months ( Fig. 3A-D) . The observed 307 decrease of LRRK2 expression in old LRRK2_D1994A animals between the 4 weeks and 3 months 308 point has to be interpreted with caution since the earlier data point is based on 4 animals only due to 309 dropouts. We generally observed a slightly lower signal intensity for LRRK2_D1994A compared to 310 LRRK2_G2019S, which became significant for both young and old animals by comparison across all 311 cohorts (Fig. 3D) . In contrast to prior work with AAV vectors in the aged rat brain (Polinski et al., 312 2015), we did not see decreased, but rather increased transduction efficiency and expression of 313 transgenic protein in the brain of old compared to young mice, potentially due to the methodological 314 adaptions chosen for the viral injections into the old mice (see section 2.2). As expected from the use 315 of HC-AdVs, our data confirm the maintenance of transgene expression even after prolonged 316 incubation time in vivo. 317
We then looked for expression of transgenic protein in the SNpc resulting from retrograde transport 318 through striatal axonal termini to nigral somata of dopaminergic cells. Up to sixteen nigral 3 µm 319 sections with defined distance were stained for TH and a section adjacent to the thereby determined 320 center of the SNpc was then stained for eGFP or LRRK2. Neither young nor old mice displayed more 321 than 10% of dopaminergic (TH+) neurons positive for transgenic protein 4 weeks or 3 months after 322 injection, despite very strong striatal eGFP or LRRK2 signal in the animals chosen for this analysis 323 (Fig. S9A) . At the same time quantification of dopaminergic neurons from young and old cohort 2 324 showed no increased neurodegeneration compared to the untreated contralateral side for any vector 325 (Fig. S9B) , indicating that inefficient retrograde transport was the reason underlying the limited nigral 326 transgene expression. As a consequence of this finding we focused our further histopathological 327 analyses on the striatum, in which LRRK2 is endogenously expressed at higher levels than in the 
Adenoviral transduction of neurons and glial cells in the mouse striatum 331
Co-staining for LRRK2 and neuronal (NeuN) or glial markers (CNPase for 332 oligodendroglia/myelinated fibers, GFAP for astrocytes, Iba1 for microglial cells) showed that our 333 HC-AdVs transduced all neural cell types, however with different efficiencies. 334
Oligodendrocytes/myelinated fibers were the preferred target, followed by astrocytes, neurons and 335 occasionally microglia (Fig. 4) and signal intensity appeared to follow the same order. We could not 336 detect endogenous LRRK2 expression in any of the mentioned cell types in eGFP expressing control 337 mice (data not shown), indicating that our treatment regimen did not induce substantial endogenous 338 LRRK2 expression. 339
Increased and prolonged inflammation-associated pathology in old mice upon 340
LRRK2_G2019S expression 341
Out of the 14 sections stained for transgenic protein, the 8 consecutive sections with the strongest 342 transgene signal were determined ( Three months after injection of HC-AdVs microglial cell counts from most of the LRRK2 expressing 367 mice had dropped to a ≤ 50% increase compared to the contralateral side (9 mice out of 14, Fig. 5K ). 368
One LRRK2_G2019S and two LRRK2_D1994A mice however developed a very strong 369 inflammatory reaction that was characterized by an increase of microglial cells by 425, 290 and 612% 370 compared to the contralateral side, loss of transgenic protein expression in the striatal matrix 371 accompanied by an atrophy of transduced cell bodies (Fig. S11B ) and a very strong upregulation of 372 the activation marker MHC-II (Fig. S11D, E) . We found only a partial co-localization of Iba1 and 373 LRRK2 signal in those mice, suggesting attraction of microglia to or microglial phagocytosis of 374 LRRK2 expressing cells rather than direct transduction (Fig. S11B, C) . These hyper-reactive mice 375
were excluded from statistical analysis. Microglial cell counts had normalized in young mice 6 mpi 376 (Fig. 5K) . Old mice in general reacted with an exaggerated increase of microglial cells upon vector 377 injection and transgene expression compared to young mice. After 3 months, similar to the GFAP 378 results, microglial cell counts started to normalize in old eGFP and LRRK2_D1994A expressing mice 379 (78/102% mean increase to contralateral, respectively), but remained significantly increased (216% 380 mean increase to contralateral) in LRRK2_G2019S mice (Fig. 5L) . we observed prominent vacuolization of striatal white fiber tracts (Wilson's pencils) in animals of 385 young and old cohort 1. This vacuolization appeared as a network of foamy spongiform holes (Fig.  386   6A) , with an increased number of phagocytic microglial cells clustering around (Fig. S10D) . LFB 387 staining demonstrated that vacuolization was associated with focal demyelination, however 3 mpi the 388 myelin fibers appeared homogenously blue again arguing for re-myelination (Fig. 6B) . Vacuolization 389 was quantified by counting the vacuoles in a defined area of central HE-stained sections from all 390 mice. Evaluation of the mean values showed an increased number of vacuoles for young 391 LRRK2_D1994A (33.5 mean) and LRRK2_G2019S mice (29.1 mean) reaching statistical 392 significance compared to eGFP mice (6.6 mean) 4 weeks after injection of HC-AdVs (Fig. 6C) . In old 393 mice, LRRK2_G2019S (41 mean) induced a significantly stronger vacuolization than 394 LRRK2_D1994A (7.8 mean) 4 wpi (Fig. 6D ). The number of vacuoles 4 wpi strongly correlated with 395 microglia cell counts in young mice while old mice just missed statistical significance (p = 0.0512) 396 (Fig. 6E, F) . At later times, vacuolization was no longer present (Fig. 6C, D) . However, we instead 397 observed a statistically significant increase of the white fiber tract area in the center of injection 3 mpi 398 (Fig. 6G, H) in the old LRRK2_G2019S mice only (+42.8% mean compared to contralateral; 399 eGFP/LRRK2: +3.37%/+4.12%). This increase correlated positively with neuron loss (Fig. 6I) . 400
No accumulation of ubiquitin, phosphorylated tau or α-synuclein 401
In the context of LRRK2 as a PD-related gene we performed immunolabeling on the histopathological 402 markers ubiquitin, phospho-tau (Ser202, Thr205) and phospho-α-synuclein (Ser129) on two central 403 striatal sections of 1-2 mice/group/cohort with high transgene expression. Functionality of the applied 404 staining procedures was confirmed on positive controls (Fig. S12A-C) . No evidence for a pathological 405 accumulation of any of the listed marker proteins was found in any of the mice analyzed (exemplary 406
shown for the respective latest times in Fig. S12D-F) . 407
Dose-dependent accumulation of p62 particularly in old LRRK2 mice 408
We finally sought to stain for the cargo receptor p62 for selective autophagy, building on 409 accumulating scientific evidence that LRRK2 is involved in the regulation of the autophagy-lysosome 410 pathway (ALP) (Manzoni, 2017) and considering that the ALP is increasingly challenged in the 411 M A N U S C R I P T
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process of aging (Rubinsztein et al., 2011) . Two animals with high-level transgene expression were 412 chosen for each group/cohort and then two central sections per animal were stained for p62. The 413 respective following serial sections were stained for the transgenic proteins. In young and old mice 414 expressing eGFP, the p62 signal was not above background at any time. In contrast, clear 415 accumulation of p62 was detected in cells expressing high levels of LRRK2_D1994A and 416 LRRK2_G2019S in young and old LRRK2 animals (Fig. 7A, B) . Thereby accumulation of p62 was 417 more pronounced in old mice (Fig. 7C) . The cell types in which p62 accumulated showed variable 418 morphology (Fig. 7D) . In a fluorescent co-staining of sections from old LRRK2_G2019S mice 3 wpi 419 astrocytes could be identified as one of the p62-accumulating cell types (Fig S13A) . However to our 420 (oligodendroglia and white fiber tracts) and in general also not for IbaI with rare exceptions (Fig.  426   S13C) . glial expression by using the ubiquitously active CAG promoter for expression control (Fig. 4) . This . We hypothesized that age increases the susceptibility towards LRRK2-455 mediated pathology and, in fact, found confirmatory evidence for this hypothesis when comparing 456 young and old mice with respect to inflammation, neurodegeneration and dysregulation of autophagy 457 in the striatum. 458
Due to the strong inflammatory responses observed during the initial titration experiments with 459 LRRK2_D1994A (Fig. S2A and S14B) , we decided for a moderate vector dose that was well tolerated 460 and resulted in widespread and stable transgene expression in the striatum for up to 6 months, the 461 latest point in time tested. However, this vector dose did not allow for efficient retrograde vector 462 transport resulting in only limited SNpc transduction (Fig. S9 ). This limitation of our LRRK2 model 463 with respect to its original intention as a PD model shifted the main focus of our work towards the 464 investigation of the age-related susceptibility of a primarily glia-mediated LRRK2 pathology upon 465 chronic expression in the striatum, the brain area with the highest endogenous LRRK2 levels (Galter Myelinated fibers and oligodendroglia were the preferred target of our vectors and vacuolization of 469 white fiber tracts as well as associated demyelination were an unexpected but prominent phenotype in 470 LRRK2 mice 4 wpi (Fig. 6 ). To our knowledge nothing comparable has been described in the context 471 of PD. Yet it appeared important to us to elaborate on these finding for two reasons. however the doses applied within this study were much lower (2E+06 IU) and no vacuolization was 483 seen in eGFP mice. Nevertheless we cannot exclude that LRRK2 may have had an enhancing, 484 additive or sensitizing effect to adenoviral capsid toxicity when expressed in glial cells. In this case 485 vacuolization would be a model-specific phenotype that however still would highlight a pro-486 inflammatory role of LRRK2 in the course of an innate immune response. 487
In parallel to the observed vacuolization, we detected an accumulation of microglia in the area of HC-488
AdV injection, the extent of which depended on the transgenic protein as well as on age (Fig. 5K, L) . 489 LRRK2 expressing mice had higher numbers of microglia compared to eGFP expressing mice, and 490 old mice had higher numbers than young mice, indicating that both, LRRK2 and age were pro- The synergistic effect of the factor age, which we report here, is new, but consistent with the 498 postulated "primed" phenotype of aged microglial cells, making them hyper-responsive to 499 inflammatory stimuli (reviewed by Norden and Godbout, 2013) represented in this study by the 500 adenoviral capsid on the one hand and the damaged white fiber tracts on the other hand. Prolonged 501 duration of an inflammatory response has been described in the aged brain (Huang, Henry et al.,  502 2008). Interestingly, we found that this was especially the case for LRRK2_G2019S, where the 503 number of microglial cells had decreased only marginally 3 mpi. Similar to the effects seen in 504 microglial cells, astrocytes presented with a reactive status upon adenoviral vector delivery and 505 overexpression of LRRK2 that was maintained for the G2019S variant in old mice, likely because age 506 drives astrocytes into a pro-inflammatory status (Jiang and Cadenas, 2014) (Fig. 5E, F) . Studies 507 investigating LRRK2 function in astrocytes so far have been mostly restricted to the autophagy-508 lysosome pathway (ALP) that appears to be negatively regulated by kinase-overactive LRRK2 509 (Henry et al., 2015; Manzoni et al., 2016 Manzoni et al., , 2013 . However, one study showed a reduction of IL-6 510 secretion upon inhibition of LRRK2 in IL-1β stimulated primary astrocytes suggesting that LRRK2 511 had a pro-inflammatory impact on those cells (Munoz et al., 2015) . Confirmatory evidence for this 512 hypothesis has to be awaited but will be especially relevant in the context of age. A simultaneous 513 increase of immunoreactivity for Iba1 and GFAP as observed in this study has also been described in 514 a very recent publication after systemic application of LPS to aged WT or LRRK2_G2019S 515 transgenic mice (Kim et al., 2017) . In contrast another study investigating Iba1 and GFAP 516 immunohistochemistry after systemic LPS or IFNγ administration to young adult WT or 517 LRRK2_G2019S transgenic mice reported no impact on astrocytes or microglia very likely due to the 518 early time point of analysis (90 min after i.p. administration) (Litteljohn et al., 2017) . 519
Importantly vacuolization, the increased number of microglial cells and astrogliosis resolved with 520 progressing time although LRRK2 protein levels remained largely stable. This finding argues for 521 . Since in our study the 527 adenoviral proteins were only transiently present the inflammation was shut down at later time points, 528 albeit with still significantly increased microglia counts and astroglia area in the aged 529
LRRK2_G2019S mice. 530
In our study we have furthermore demonstrated that neurons of old but not young LRRK2_G2019S 531 mice were significantly reduced at 3 mpi (Fig. 5H, I ) but not at 4 wpi, indicating progressive 532 e.g. autophagy failure will require further study. However, the strong inflammatory reaction and white 537 fiber tract-vacuolization preceding neuron loss argue for a scenario in which neurons have died as a 538 consequence of a neurotoxic microenvironment. The positive correlation of the white fiber tract area 539 and the extent of neuron loss most likely depicts a kind of scar formation in this scenario (Fig. 6I) . 540
Our data showing accumulation of p62 upon high level LRRK2 expression, especially in old mice 541 (Fig. 7) , suggest that also dysregulation of autophagy may have contributed to neuronal damage. (Fig.  545   S13) . 546
By comparing LRRK2_G2019S and LRRK2_D1994A we wanted to evaluate the relevance of kinase-547 activity with regard to age-related LRRK2 pathology. We found that in young mice, vacuolization, 548 increase of microglia and accumulation of p62 was largely independent on kinase-activity. In old 549 mice, except for p62, all effects were restricted to the pathogenic LRRK2_G2019S mutant 550 M A N U S C R I P T
A C C E P T E D ACCEPTED MANUSCRIPT (vacuolization, prolonged microglia accumulation and astrogliosis as well as neurodegeneration). 551
Since kinase-inactive D1994X mutants display lower protein stability (Biosa et al., 2013; Herzig et 552 al., 2011; Tsika et al., 2015) and protein signal in old LRRK2_D1994A mice had significantly 553 decreased from 4 wpi to 3 mpi (Fig. 3A) , it is difficult to determine whether protein level or kinase-554 activity was the crucial factor for pathology. It is questionable however, to what extent these two can 555 be separated since kinase-activity and protein levels appear to be inextricably linked to each other as 556 demonstrated extensively in vitro and in vivo (Fell et LRRK2_D1994A overexpression in our initial titration experiment and having noted that both 559 LRRK2 mutants but not eGFP caused neuronal degeneration in vitro when applied at high dose (iMOI 560 500, Fig. S14 ), we believe that the protein level of LRRK2 plays an important role for its toxicity. 561 However, it is still possible that the functional difference regarding kinase-activity contributed to the 562 different pathogenicity seen in old mice. A LRRK2_WT encoding HC-AdV could clarify this 563 question as long as protein levels were comparable between LRRK2_WT and _G2019S. 564
In summary, our study indicates that age is a crucial factor for manifestation of pathologic effects of 565 LRRK2_G2019S in the mouse striatum. Whereas young mice were able to cope with transient 566 pathology and did not experience permanent damage over 6 months of high-level expression, old mice 567 were more susceptible to inflammation mediated by activated LRRK2_G2019S and suffered 568 permanent neurodegeneration within 3 months. This is evocative of the age-dependent penetrance of 569 PD in LRRK2 mutant carriers. Furthermore the prompt pathological reaction of oligodendrocyte-570 derived myelin sheets, astrocytes and microglia and the inappropriately long maintained reactive 571 profile of aged microglia and astrocytes upon LRRK2_G2019S expression argues against a pure 572 bystander role of glial cells. Inclusion of age, long-term effects and glial cells in our study on LRRK2 573 revealed important aspects that may be of special importance in diseases that develop progressively 574 were either 4 weeks, 3 or 6 months after injection. Due to their age, old mice were not eligible for 12 cohort 3. Each cohort consisted of 27 animals (old cohort 1 only 21) comprising 3 treatment groups: 13 eGFP, LRRK2_D1994A and LRRK2_G2019S HC-AdV. Mice were weighed twice a week, their nest 14 building skills were assessed once a week and they were screened for motor behavior in the open field 15 test (OF) every week (cohort 1) or every 4 weeks (cohorts 2 and 3). At the respective endpoints, the 16 brain was analyzed for transgene expression (LRRK2/GFP), neurodegeneration (NeuN), 17 dopaminergic cells and fibers (TH), astrogliosis (GFAP), inflammation (Iba1), aggregate formation 18 (ubiquitin, tau pS202, pT205, α-syn pS129) and autophagy dysfunction (p62). 19 
